Please assess the completion status of the following clinical trial:

Trial Title: Postplacental Insertion of Levonorgestrel-releasing Intrauterine System (LNG-IUS) After Cesarean vs. Interval Insertion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pregnant at time of enrollment~* Planning to undergo a scheduled cesarean delivery~* Desires to use the LNG-IUS for contraception~* Willing and able to sign an informed consent in English~* Willing to comply with the study protocol~* Age greater than or equal to 18 years~* English speaking~Exclusion Criteria:~* Allergy to either polyethylene or levonorgestrel, or other contraindications to use of the LNG-IUS~* Positive testing for Gonorrhea, Chlamydia, or trichomoniasis during the pregnancy without treatment and a subsequent test of cure confirming a negative result~* Presence of leiomyomata significantly distorting the uterine cavity and thus not allowing placement of the LNG-IUS~* Uterine anomaly which would not allow placement of the LNG-IUS~* Current cervical cancer or carcinoma in-situ~* Desire for repeat pregnancy in less than 12 months~* History of postabortal or postpartum sepsis

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- postplacental insertion after cesarean (Type: EXPERIMENTAL): Immediate postplacental insertion of the LNG-IUS through the uterine incision during cesarean, within 10 minutes after delivery of the placenta~Device of intervention: Levonorgestrel-releasing intrauterine system (LNG-IUS)
- delayed insertion group (Type: ACTIVE_COMPARATOR): Insertion of the LNG-IUS 4-8 weeks after cesarean delivery~Device of intervention: Levonorgestrel-releasing intrauterine system (LNG-IUS)

Based on this trial design, predict the completion outcome and termination type (if applicable).